Thermo Fisher Scientific, & Abbott Laboratories are Key Players in the Genetic Testing Market

The global genetic testing market was valued at $12 billion in 2019, and is expected to reach $21 billion by 2027, registering a CAGR of 10.1% from 2019 to 2027.

• CAGR: 10.1%
• Current Market Size: USD 12 Billion
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2019- 2027
• Base Year: 2019

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞-
https://www.alliedmarketresearch.com/request-sample/5241

The field of genomics has revolutionized healthcare by providing insights into the genetic makeup of individuals, enabling personalized treatment and disease prevention strategies. Two industry giants, Thermo Fisher Scientific, Inc. and Abbott Laboratories, have emerged as dominant forces in the genetic testing market, harnessing the power of genomics to drive advancements in healthcare.

Thermo Fisher Scientific, Inc., a global leader in scientific research and diagnostic solutions, has made significant contributions to the genetic testing market. With a comprehensive portfolio of cutting-edge technologies and assays, Thermo Fisher enables accurate and efficient analysis of genetic information. Their innovative platforms, such as Ion Torrent™ and Applied Biosystems™, empower researchers and healthcare professionals to unlock the potential of genomics in various applications, including cancer diagnostics, inherited disease screening, and pharmacogenomics.

Abbott Laboratories, a renowned healthcare company with a strong focus on diagnostics, has also made remarkable strides in the genetic testing arena. Leveraging their expertise in molecular diagnostics, Abbott has developed state-of-the-art platforms like the Abbott RealTime PCR system and the Alinity™ m molecular diagnostics system. These advanced tools enable rapid and reliable genetic testing, enabling timely diagnoses, informed treatment decisions, and monitoring of therapeutic efficacy.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (247 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/genetic-testing-market/purchase-options

The dominance of Thermo Fisher Scientific, Inc. and Abbott Laboratories in the genetic testing market stems from their commitment to innovation, quality, and reliability. Both companies invest heavily in research and development to enhance their testing platforms and expand the range of genetic markers and diseases covered. By collaborating with leading research institutions and healthcare providers, they ensure that their solutions align with the evolving needs of the medical community.

Beyond their technological advancements, Thermo Fisher Scientific, Inc. and Abbott Laboratories prioritize regulatory compliance and quality assurance, instilling confidence in their customers and end-users. They adhere to rigorous standards and guidelines, including FDA approvals and ISO certifications, to ensure the accuracy and reliability of their genetic testing solutions. This dedication to quality has propelled them to the forefront of the genetic testing market.

As the genetic testing market continues to grow, Thermo Fisher Scientific, Inc. and Abbott Laboratories stand as unrivaled leaders, spearheading the transformation of healthcare through genomics. Their commitment to innovation, technological advancements, and stringent quality standards places them in a dominant position, shaping the future of genetic testing and personalized medicine. With their continued efforts, they will undoubtedly play a pivotal role in uncovering the untapped potential of genomics and driving improved patient outcomes worldwide.

𝐃𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 - https://www.alliedmarketresearch.com/purchase-enquiry/5241

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
By type, the prenatal & newborn testing segment occupied one-thirds share of the global genetic testing market in 2019
By technology, the biochemical testing segment is anticipated to grow with the highest CAGR throughout the forecast period.
By application, the genetic disease diagnosis segment accounted for more than one-thirds share of the market in 2019.
By region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period.

𝐆𝐞𝐧𝐞𝐭𝐢𝐜 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 -
• ABBOTT laboratories,
• BIO-RAD LABORATORIES, INC. (RAINDANCE TECHNOLOGIES, INC.),
• CSL LTD,
• DANAHER CORPORATION (CEPHEID),
• EUROFINS SCIENTIFIC,
• F. HOFFMANN-LA ROCHE LTD,
• ILLUMINA, INC,
• MYRIAD GENETICS, INC. (MYRIAD RBM, INC.),
• QIAGEN N.V. (FORMULATRIX, INC.),
• THERMO FISHER SCIENTIFIC, INC

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞 - https://www.alliedmarketresearch.com/genetic-testing-market

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧
𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/connected-drug-delivery-devices-market-A26017

𝐃𝐞𝐧𝐭𝐮𝐫𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/dentures-market-A31457

𝐏𝐞𝐩𝐭𝐢𝐝𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/peptide-therapeutics-market-A11226

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.